Popular chip brand recalled at highest risk level in Oregon, Washington
The Food and Drug Administration (FDA) increased a major recall on Lay’s potato chips sold in stores across Oregon and Washington.
FDA elevates Lay's potato chip recall in Oregon, Washington to highest risk level
Class I, according to the FDA, means exposure to or consumption of the product could cause "serious adverse health consequences or death."
Recalled potato chips sold in Oregon and Washington could cause ‘serious adverse health consequences’
The Food and Drug Administration has newly classified the December recall of some Lay’s Classic Potato Chips sold in Oregon and Washington with the designation reserved for the highest degree of health hazard.
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most were in favor of the change and agreed that, if finalized, the labels would help them make better-informed nutrition choices.
FDA upgrades Oregon, Washington recall for Lay's Classic Potato Chips to highest level
The FDA upgraded a recall for Lay's Classic Potato Chips to the highest risk level for packages distributed in Oregon and Washington.
FDA issues Class 1 alert for Lay's chips recall in Oregon and Washington
The Food and Drug Administration has issued a Class 1 alert after Frito-Lay issued a recall for bags of Lay’s potato chips sold in Oregon and Washington.
Lay’s potato chips in Washington, Oregon recalled
Some 13-ounce bags of Lay's Classic Potato Chips have been recalled due to undeclared milk. No allergic reactions have been reported thus far.
As Trump and RFK Jr. move to upend drug making, Seattle biotech bets on science
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech sector, but industry leaders believe science may carry the day.
CNN on MSN8d
Trump administration directs federal health agencies to pause communications
Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external communications, such as regular scientific reports, updates to websites and health advisories,
As RFK Jr. faces Senate confirmation hearings, here's where he stands on vaccines, food dyes
As Robert F. Kennedy Jr. faces his Senate confirmation hearings to lead the HHS, here's where he stands on health issues including vaccines and food dyes.
Trump Administration Orders a Temporary Freeze on Food and Health Agency Communications
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has instructed the heads of every federal health agency to stop public communication.
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.